methamphetamine has been researched along with luteolin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, T; Li, L; Li, T; Liu, F; Liu, X; Sun, B; Yan, T; Yang, P | 1 |
Chen, LJ; Li, JH; Qu, D; Tan, XH; Wang, HJ; Wang, Q; Xie, XL; Xu, JT; Zhang, KK | 1 |
2 other study(ies) available for methamphetamine and luteolin
Article | Year |
---|---|
Luteolin inhibits behavioral sensitization by blocking methamphetamine-induced MAPK pathway activation in the caudate putamen in mice.
Topics: Animals; JNK Mitogen-Activated Protein Kinases; Luteolin; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Motor Activity; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-fos; Putamen; Signal Transduction | 2014 |
Luteolin alleviates methamphetamine-induced neurotoxicity by suppressing PI3K/Akt pathway-modulated apoptosis and autophagy in rats.
Topics: Animals; Apoptosis; Autophagy; Gene Expression; Luteolin; Male; Methamphetamine; Neurotoxicity Syndromes; Phosphatidylinositol 3-Kinases; Principal Component Analysis; Protective Agents; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction | 2020 |